NautaDutilh assists the Netherlands Center for the Clinical advancement of Stem Cell and Gene Therapies (NECSTGEN) with regard to the construction of its new facility at the Leiden Bio Science Park. Measuring four thousand square meters, it will be one of the largest non-profit stem cell and gene therapy facilities in Europe. Academic researchers and start-up companies can use the facility to work on stem cell and gene therapy products in the field of regenerative medicine, specifically in the phase between scientific breakthroughs in the laboratory and application in the clinic.
There are few facilities such as NECSTGEN around the world: affordable, non-profit facilities that facilitate the product development of regenerative medical treatments – treatments that restore or replace diseased cells, tissues and organs. Regenerative medicine is considered a great promise in the pharmaceutical industry. The NECSTGEN is needed to test breakthroughs, develop them further and make them available to patients more quickly. The NECSTGEN, scheduled to open at the end of this year or early 2021, will help to further strengthen the Netherlands life science and biotech ecosystem.
The NautaDutilh team advising NECSTGEN consists of David van Dijk, Ramon Pop, David van Ee and Ruud Smits.